Insight Molecular Diagnostics Statistics
NASDAQ: IMDXHealthcareDiagnostics & ResearchUSD
3.28-0.18 (-5.20%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Insight Molecular Diagnostics by the numbers
Insight Molecular Diagnostics has a market capitalization of $107.3 million based on 32.72M shares outstanding. With trailing EPS of $-1.52, Insight Molecular Diagnostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.7% below its 50-day average and 35.1% below its 200-day average.
Average daily trading volume is 233.13K shares, or about $764,683 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMDX valuation vs. peer median
| Metric | IMDX | Peer median | Difference |
|---|---|---|---|
| Market cap | $107.34M | $9.50M | +1030% |
| Avg. volume | 233.13K | 399.73K | -42% |
Peer median across 8 companies: MDXH, BNR, PRPO, ADVB, NDRA, XWEL, BIAF, ISPC.
Valuation
- Market cap
- $107.34M
- EPS (TTM)
- $-1.52
- Shares outstanding
- 32.72M
Price and trading
- Previous close
- 3.46
- Open
- 3.44
- Day range
- 3.08 – 3.56
- 52-week range
- 2.42 – 8.51
- 52-week change
- -5.98%
- Beta
- —
- Volume
- 227.22K
- Average volume
- 233.13K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 10, 2026
Additional statistics
- Market Cap
- 107.34M
- Forward Pe
- -4.10
- Eps
- -1.52
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.51
- Week52 Low
- 2.42
- Avg Volume
- 233.13K
- Shares Outstanding
- 32.72M
- Ma50
- 4.14
- Ma200
- 5.05
- Earnings Date
- Aug 10, 2026
- Pct From52w High
- -61.46%
- Pct From52w Low
- 35.54%